| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/18/2009 | CN100462074C Chewing tablet with vision fatigue relieving function |
| 02/18/2009 | CN100462072C Medicine composition used for injection and its preparing method |
| 02/18/2009 | CN100462071C Sustained release Brufen having magnetic super-molecular inserting layer structure and its preparation method |
| 02/18/2009 | CN100462070C Retinoic acid release control nanomicrosphere and its preparation method |
| 02/18/2009 | CN100462067C Preparation method of sodium iron chlorophyllin-ethyl cellulose microcapsule |
| 02/18/2009 | CN100462066C Novel formulations of pharmacological agents, method for preparation thereof and method for use thereof |
| 02/17/2009 | USRE40640 Injectable microfoam containing a sclerosing agent |
| 02/17/2009 | US7491836 Polyoxyalkylene glycols or monoalkylated polyoxyalkylene glycols esterified with O-acylated, O-alkylated or O-alkenylated hydroxy fatty acids; high bioavailability |
| 02/17/2009 | US7491796 Retro-inversion peptides that target GIT receptors and related methods |
| 02/17/2009 | US7491707 Synthetic lipid-a-analogs and uses thereof |
| 02/17/2009 | US7491701 Peptides that bind to HSP90 proteins |
| 02/17/2009 | US7491692 admixing a supplement selected from the therapeutically active agents for facilitating axon growth and a flowable carrier component capable of forming a matrix in vivo at a nerve lesion site and the active agent is releasable from the matrix |
| 02/17/2009 | US7491411 dialysis or replacement fluid separated into two or more component solutions intended for admixture to use, provides the final dialysis or replacement fluid; aqueous NaHCO3 in one compartment, dissolved CO2 in separate compartment containing HCl or lactic or CH3COOH, NaCl, MgCl2, KCl, CaCl2, glucose |
| 02/17/2009 | US7491409 Dissolving an amphipathic lipid in a solvent, combining dna or rna containing aqueous suspension with lipid solution to form water-in -oil emulsion, adding a polycation ( polylysine, polyhistidine, spermine, spermidine) to the emulsion, incubating to complex nucleic acid with polycation, removing solvent |
| 02/17/2009 | US7491407 Fiber-based nano drug delivery systems (NDDS) |
| 02/17/2009 | US7491406 Fast dissolving orally consumable films |
| 02/17/2009 | US7491395 Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination |
| 02/17/2009 | US7491383 Solubilizer, and a anionic polymer or fatty acid in complex with a therapeutic |
| 02/17/2009 | US7491047 Delivery of antihistamines through an inhalation route |
| 02/17/2009 | US7490603 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 02/17/2009 | CA2383785C Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| 02/17/2009 | CA2381404C Ointment applicator and ointment patch using the same |
| 02/17/2009 | CA2356087C Methods and compositions for treatment of cell proliferative disorders |
| 02/17/2009 | CA2355283C Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/17/2009 | CA2347856C Dry powder for inhalation |
| 02/17/2009 | CA2325983C Drug delivery of proteins from polymeric blends |
| 02/17/2009 | CA2316976C Osmotic delivery system with membrane plug retention mechanism |
| 02/17/2009 | CA2299464C Controlled release pharmaceutical compositions containing tiagabine |
| 02/17/2009 | CA2233166C Hormone immunomodulated induction of mucosal immune responses |
| 02/17/2009 | CA2231404C Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 02/16/2009 | CA2696400A1 Hemostatic agent composition and method of delivery |
| 02/12/2009 | WO2009021127A2 Controlled released compositions |
| 02/12/2009 | WO2009021106A1 Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms |
| 02/12/2009 | WO2009021048A2 Microneedle arrays formed from polymer films |
| 02/12/2009 | WO2009021017A2 Nucleic acid-lipopolymer compositions |
| 02/12/2009 | WO2009020987A2 Process for preparation of swellable and degradable microspheres |
| 02/12/2009 | WO2009020744A1 Protein formulations comprising gdf-5 in aqueous acidic solution |
| 02/12/2009 | WO2009020607A2 Method and apparatus for composite drug delivery medical devices |
| 02/12/2009 | WO2009020595A2 Nutritional supplement system |
| 02/12/2009 | WO2009020434A1 A process for making micro-sized protein particles |
| 02/12/2009 | WO2009020317A2 Stabilized antioxidant particles, composition comprising the same and method for preparing the same |
| 02/12/2009 | WO2009020314A2 Stabilized alpha-lipoic acid particles, composition comprising the same and method for preparing the same |
| 02/12/2009 | WO2009020268A1 Composition for manufacturing orally disintegrating dosage form to protect coating layer of active substance |
| 02/12/2009 | WO2009020192A1 Composition for oral intake for preventing ultraviolet damage |
| 02/12/2009 | WO2009020145A1 Two-component eye drops containing pirenoxine |
| 02/12/2009 | WO2009020104A1 Gel-like composition for external application comprising adenine compound |
| 02/12/2009 | WO2009020094A1 Antibody modified with hydrophobic molecule |
| 02/12/2009 | WO2009020093A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 02/12/2009 | WO2009019891A1 Inverted vesicle |
| 02/12/2009 | WO2009019835A1 Crude drug extract-blended liquid medicine |
| 02/12/2009 | WO2009019662A2 Oral metaxalone compositions |
| 02/12/2009 | WO2009019599A2 Extended release compositions comprising tolterodine |
| 02/12/2009 | WO2009019593A1 Pellet for animals and method for its production |
| 02/12/2009 | WO2009019571A2 Method of dissolving essential oils in water |
| 02/12/2009 | WO2009019499A2 Improvements relating to skin dressings |
| 02/12/2009 | WO2009019498A2 Improvements relating to skin dressings |
| 02/12/2009 | WO2009019463A1 Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue |
| 02/12/2009 | WO2009019385A1 Use of eflucimibe for the production of a medicament for the prevention or treatment of a disease caused by sebaceous gland dysfunction in humans or animals |
| 02/12/2009 | WO2009019371A2 Use of a material based on a thermoplastic polymer having a high content of antioxidants for packaging dianhydrohexitols |
| 02/12/2009 | WO2009019307A2 Oral calcitonin compositions and applications thereof |
| 02/12/2009 | WO2009019294A2 Bupropion hydrobromide and therapeutic applications |
| 02/12/2009 | WO2009018834A1 Pharmaceutical composition containing bisphosphonate and method for the preparation thereof |
| 02/12/2009 | WO2009002703A3 Ophthalmic solutions |
| 02/12/2009 | WO2008155592A3 Liposome composition |
| 02/12/2009 | WO2008153945A3 Nutraceutical co-crystal compositions |
| 02/12/2009 | WO2008152669A3 Colloidal vectors with polyaminoacid structure for oral release of peptides and proteins and method for their production |
| 02/12/2009 | WO2008142572A3 Controlled release tablet formulation containing magnesium aluminometasilicate |
| 02/12/2009 | WO2008142231A3 Novel composition based on cholest-4-ene-3-one oxime |
| 02/12/2009 | WO2008135527A3 Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
| 02/12/2009 | WO2008128028A3 Solifenacin compositions |
| 02/12/2009 | WO2008100481A3 Lung cancer-targeted peptides and applications thereof |
| 02/12/2009 | WO2008089426A3 Methods and compositions for the delivery of a therapeutic agent |
| 02/12/2009 | WO2008076780A3 Amorphous valsartan and the production thereof |
| 02/12/2009 | WO2008068584A3 A heterogeneously configured multiparticulate gastrointestinal drug delivery system |
| 02/12/2009 | WO2008064163A3 Polymer coated drug-ion exchange resins and methods |
| 02/12/2009 | WO2008060360A3 Implantable medical device with apertures for delivery of bioactive agents |
| 02/12/2009 | WO2008054823A4 Bolus materials for radiation therapy and methods of making and using the same |
| 02/12/2009 | WO2008038292A3 Use of glycerophospholipids for joint lubrication |
| 02/12/2009 | WO2008035020A3 Galenic form for the trans-mucosal delivery of active ingredients |
| 02/12/2009 | WO2008034120A3 Lysine-based polymeric linkers |
| 02/12/2009 | WO2007139827A8 Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses |
| 02/12/2009 | WO2007057891A3 Methods and kits for detecting fungal infection |
| 02/12/2009 | US20090043379 Drug delivery systems for the prevention and treatment of vascular diseases |
| 02/12/2009 | US20090043291 Closed Loop Medicament Pump |
| 02/12/2009 | US20090043288 Temperature responsive systems |
| 02/12/2009 | US20090043250 Microneedle with membrane |
| 02/12/2009 | US20090042989 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 02/12/2009 | US20090042970 Methods and devices for desmopressin drug delivery |
| 02/12/2009 | US20090042952 Sustained Release Composition for Oral Administration of Niacin |
| 02/12/2009 | US20090042950 Silicone to adjust release profile of active materials; topical applying to skins with penetration promoter and volatile solvent |
| 02/12/2009 | US20090042940 Methods and compositions using cholinesterase inhibitors |
| 02/12/2009 | US20090042939 Methods and Compositions Using Cholinesterase Inhibitors |
| 02/12/2009 | US20090042914 Delayed release formulations of 6-mercaptopurine |
| 02/12/2009 | US20090042911 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/12/2009 | US20090042827 Antiviral oligonucleotides targeting hbv |
| 02/12/2009 | US20090042791 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 02/12/2009 | US20090041852 Dry powder compositions and systems for poultry vaccination |
| 02/12/2009 | US20090041851 Composition for the delivery of live cells and methods of use thereof |
| 02/12/2009 | US20090041850 Process for preparation of swellable and degradable microspheres |
| 02/12/2009 | US20090041849 Dissolution aids for oral peptide delivery comprising a biguanide |